Overall, the study provides new information regarding the role of mGlu2/3 in post-methamphetamine cognitive deficits, though it does not directly address the relationship between observed deficit and motivation to seek the drug and fails to consider cellular and regional diversity of mGlu2/3 function. The gene discussed is GRM2; the disease is Cognitive impairment.